These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26674120)

  • 1. ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers.
    Abdel-Fatah TM; Arora A; Moseley P; Coveney C; Perry C; Johnson K; Kent C; Ball G; Chan S; Madhusudan S
    BBA Clin; 2014 Dec; 2():10-7. PubMed ID: 26674120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-PKcs, ATM, and ATR Interplay Maintains Genome Integrity during Neurogenesis.
    Enriquez-Rios V; Dumitrache LC; Downing SM; Li Y; Brown EJ; Russell HR; McKinnon PJ
    J Neurosci; 2017 Jan; 37(4):893-905. PubMed ID: 28123024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.
    Lee B; Lee HJ; Cho HY; Suh DH; Kim K; No JH; Kim H; Kim YB
    Anticancer Res; 2015 Jul; 35(7):3909-16. PubMed ID: 26124337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of DNA-PKcs enhances radiosensitivity and increases the levels of ATM and ATR in NSCLC cells exposed to carbon ion irradiation.
    Yang L; Liu Y; Sun C; Yang X; Yang Z; Ran J; Zhang Q; Zhang H; Wang X; Wang X
    Oncol Lett; 2015 Nov; 10(5):2856-2864. PubMed ID: 26722253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
    Cui Y; Palii SS; Innes CL; Paules RS
    Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers.
    Savva C; De Souza K; Ali R; Rakha EA; Green AR; Madhusudan S
    Breast Cancer Res Treat; 2019 May; 175(1):105-115. PubMed ID: 30746633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition ≠ deletion.
    Menolfi D; Zha S
    Cell Biosci; 2020; 10():8. PubMed ID: 32015826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells.
    Tomimatsu N; Mukherjee B; Burma S
    EMBO Rep; 2009 Jun; 10(6):629-35. PubMed ID: 19444312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.
    Falck J; Coates J; Jackson SP
    Nature; 2005 Mar; 434(7033):605-11. PubMed ID: 15758953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift in G
    Li F; Mladenov E; Dueva R; Stuschke M; Timmermann B; Iliakis G
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATR Contributes More Than ATM in Intra-S-Phase Checkpoint Activation after IR, and DNA-PKcs Facilitates Recovery: Evidence for Modular Integration of ATM/ATR/DNA-PKcs Functions.
    Soni A; Duan X; Stuschke M; Iliakis G
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases.
    Yajima H; Lee KJ; Zhang S; Kobayashi J; Chen BP
    J Mol Biol; 2009 Jan; 385(3):800-10. PubMed ID: 19071136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition.
    Middleton FK; Patterson MJ; Elstob CJ; Fordham S; Herriott A; Wade MA; McCormick A; Edmondson R; May FE; Allan JM; Pollard JR; Curtin NJ
    Oncotarget; 2015 Oct; 6(32):32396-409. PubMed ID: 26486089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation.
    Saha J; Wang M; Cucinotta FA
    DNA Repair (Amst); 2013 Dec; 12(12):1143-51. PubMed ID: 24238855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATR-dependent phosphorylation of DNA-dependent protein kinase catalytic subunit in response to UV-induced replication stress.
    Yajima H; Lee KJ; Chen BP
    Mol Cell Biol; 2006 Oct; 26(20):7520-8. PubMed ID: 16908529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer.
    Hofstad M; Woods A; Parra K; Sychev ZE; Mazzagatti A; Yu L; Gilbreath C; Ly P; Drake JM; Kittler R
    bioRxiv; 2024 Jul; ():. PubMed ID: 39026771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress.
    Liu S; Opiyo SO; Manthey K; Glanzer JG; Ashley AK; Amerin C; Troksa K; Shrivastav M; Nickoloff JA; Oakley GG
    Nucleic Acids Res; 2012 Nov; 40(21):10780-94. PubMed ID: 22977173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer.
    Xing J; Wu X; Vaporciyan AA; Spitz MR; Gu J
    Cancer; 2008 Jun; 112(12):2756-64. PubMed ID: 18457328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function.
    Menezes DL; Holt J; Tang Y; Feng J; Barsanti P; Pan Y; Ghoddusi M; Zhang W; Thomas G; Holash J; Lees E; Taricani L
    Mol Cancer Res; 2015 Jan; 13(1):120-9. PubMed ID: 25232030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints.
    Ivy SP; Kunos CA; Arnaldez FI; Kohn EC
    Expert Opin Investig Drugs; 2019 Sep; 28(9):771-785. PubMed ID: 31449760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.